Evidence map›Paper›PMID 21642531›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Multiplexed RNA structure characterization with selective 2'-hydroxyl acylation analyzed by primer extension sequencing (SHAPE-Seq).

Julius B Lucks, Stefanie A Mortimer, Cole Trapnell, Shujun Luo, Sharon Aviran, Gary P Schroth, Lior Pachter, Jennifer A Doudna, Adam P Arkin

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 235 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
235citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

235 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Reply to Chi et al.: DefiningProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. mNature communications · 2026
    Article
  6. Review
  7. Review
  8. Optimized tRNA structure-seq reveals robust tRNA secondary structures inbioRxiv : the preprint server for biology · 2026
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. SINEUP RNA rescues molecular phenotypes associated with CHD8 suppression in autism spectrum disorder model systems.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article

175 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Julius B LucksDepartment of Bioengineering, University of California, Berkeley, CA 94720, USA. jblucks@cornell.edu
Stefanie A Mortimer
Cole Trapnell
Shujun Luo
Sharon Aviran
Gary P Schroth
Lior Pachter
Jennifer A Doudna
Adam P Arkin

Funding

Howard Hughes Medical Institute
6 · The paper itself

Abstract

New regulatory roles continue to emerge for both natural and engineered noncoding RNAs, many of which have specific secondary and tertiary structures essential to their function. Thus there is a growing need to develop technologies that enable rapid characterization of structural features within complex RNA populations. We have developed a high-throughput technique, SHAPE-Seq, that can simultaneously measure quantitative, single nucleotide-resolution secondary and tertiary structural information for hundreds of RNA molecules of arbitrary sequence. SHAPE-Seq combines selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE) chemistry with multiplexed paired-end deep sequencing of primer extension products. This generates millions of sequencing reads, which are then analyzed using a fully automated data analysis pipeline, based on a rigorous maximum likelihood model of the SHAPE-Seq experiment. We demonstrate the ability of SHAPE-Seq to accurately infer secondary and tertiary structural information, detect subtle conformational changes due to single nucleotide point mutations, and simultaneously measure the structures of a complex pool of different RNA molecules. SHAPE-Seq thus represents a powerful step toward making the study of RNA secondary and tertiary structures high throughput and accessible to a wide array of scientific pursuits, from fundamental biological investigations to engineering RNA for synthetic biological systems.

Indexed as

Nucleic Acid ConformationBacillus subtilisBase SequenceComputational BiologyDNA Barcoding, TaxonomicDNA PrimersHigh-Throughput Nucleotide SequencingModels, MolecularMolecular ProbesMolecular Sequence DataMolecular StructurePoint MutationRibonuclease PRNARNA, CatalyticSequence Analysis, RNADNA PrimersMolecular ProbesRibonuclease PRNARNA, Catalytic

Identifiers

PMID21642531
PMCPMC3131332

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.